Cmv Rhesus Macaques Durable Neutralizing Antibvody Titers Cd4 Cd8

PepPool: EBV (CD4 and CD8), human
3641-1 One vial with 25 ug of each peptide
EUR 313.6
Description: Human

Human IgG antibody Laboratories manufactures the cmv rhesus macaques durable neutralizing antibvody titers cd4 cd8 reagents distributed by Genprice. The Cmv Rhesus Macaques Durable Neutralizing Antibvody Titers Cd4 Cd8 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rhesus Antibody. Other Cmv products are available in stock. Specificity: Cmv Category: Rhesus Group: Macaques Durable

CD4/CD8/CD3
50 test
EUR 626.28

Human CD4/CD8 antibodies combination
50 test
EUR 254.1

CD4 / CD8 Antibody (FITC, PE)
50 tests
EUR 510

CD8 / CD4 Antibody (FITC, PE)
50 tests
EUR 510

CD4 / CD8 Antibody (FITC / PE)
100 µg Ask for price

CD4 / CD8 Antibody (FITC / PE)
100 ul
EUR 427.2

CD4 / CD8 Antibody (FITC / PE)
10 µg
EUR 325

CD4 / CD8 Antibody (FITC / PE)
50 µg Ask for price

CD8 (FITC) CD4 (RPE) Antibody
50 TESTS Ask for price

CD3/CD8/CD45/CD4
50 test
EUR 849.36

CD3/CD8/CD45/CD4
50 test
EUR 730.8

CD4 FITC - CD8 PE
50Tests
EUR 345

Macaques Durable information

Anti-SARS-CoV-2 (BA.2) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)
RAS-N087 96tests
EUR 719.4
Description: A more contagious subvariant of omicron, known as BA.2, is spreading across the globe and could soon become the dominant version of Covid-19.It's now the top variant in at least 18 countries and rapidly spreading, representing 35% of all new cases that have been genetically sequenced worldwide, up from 10 countries and 21% of cases the week before, according to new data from the World Health Organization. In the U.S, BA.2 currently makes up 3.8% of genetically sequenced Covid cases, according to the Centers for Disease Control and Prevention.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure neutralizing antibodies against the mutants is in urgent need.

Anti-SARS-CoV-2 (BA.2.12.1) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)
RAS-N120 96tests
EUR 719.4
Description: The newly identified 2019 novel coronavirus (SARS-CoV-2) has posed a serious threat to human health, and it spreads quickly. It is helpful to develop the Anti SARS-CoV-2 neutralizing antibody titer serologic assay kit to test the protective neutralizing antibody level in serum.

Anti-SARS-CoV-2 (XBB.1.5) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)
RAS-N173 96tests
EUR 719.4
Description: XBB.1.5 was first identified in the United States in New York in October 2022. Both XBB and the Kraken version (XBB.1.5) are recombinant (or hybrid) virus subvariants, meaning they are made up of two strains—in this case, two offshoots of the Omicron BA.2 sublineage.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure neutralizing antibodies against the mutants is in urgent need.

Anti-SARS-CoV-2 (XBB.1.5) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)
RAS-N173-96tests 96tests
EUR 719.4
Description: XBB.1.5 was first identified in the United States in New York in October 2022. Both XBB and the Kraken version (XBB.1.5) are recombinant (or hybrid) virus subvariants, meaning they are made up of two strains—in this case, two offshoots of the Omicron BA.2 sublineage.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure neutralizing antibodies against the mutants is in urgent need.

Anti-SARS-CoV-2 (B.1.617.2) Neutralizing Antibody Titer Serologic Assay Kit (Spike Trimer)
RAS-N041 96tests
EUR 719.4
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, people ask if one possesses protective neutralizing antibodies (NAbs) against the variants after receiving the currently available vaccines; and if the NAb therapeutic agents are equally effective to treat the mutant infection as the wild type. To facilitate the mutant-related research, drug trials and vaccine assessments, a high-throughput assay to measure neutralizing antibodies against the mutants is in urgent need.

Anti-SARS-CoV-2 (BA.4 & BA.5) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)
RAS-N107 96tests
EUR 719.4
Description: The newly identified 2019 novel coronavirus (SARS-CoV-2) has posed a serious threat to human health, and it spreads quickly. It is helpful to develop the Anti SARS-CoV-2 neutralizing antibody titer serologic assay kit to test the protective neutralizing antibody level in serum.

IL-6R/CD126 Neutralizing Antibody
MBS8102650-02mg 0.2mg
EUR 280

IL-6R/CD126 Neutralizing Antibody
MBS8102650-05mg 0.5mg
EUR 375

IL-6R/CD126 Neutralizing Antibody
MBS8102650-5x05mg 5x0.5mg
EUR 1545

IL-4R/CD124 Neutralizing Antibody
MBS8102675-02mg 0.2mg
EUR 280

IL-4R/CD124 Neutralizing Antibody
MBS8102675-05mg 0.5mg
EUR 375

IL-4R/CD124 Neutralizing Antibody
MBS8102675-5x05mg 5x0.5mg
EUR 1545

IL-4R/CD124 Neutralizing Antibody
MBS8102681-02mg 0.2mg
EUR 280

IL-4R/CD124 Neutralizing Antibody
MBS8102681-05mg 0.5mg
EUR 375

IL-4R/CD124 Neutralizing Antibody
MBS8102681-5x05mg 5x0.5mg
EUR 1545

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102538-02mg 0.2mg
EUR 280

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102538-05mg 0.5mg
EUR 375

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102538-5x05mg 5x0.5mg
EUR 1545

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102539-02mg 0.2mg
EUR 375

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102539-05mg 0.5mg
EUR 530

PD1/PDCD1/CD279 Neutralizing Antibody
MBS8102539-5x05mg 5x0.5mg
EUR 2230

Anti-CTLA4 (CD152) Neutralizing Antibody
71212 100 µg
EUR 490
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species.

Anti-PD-L1 (CD274) Neutralizing Antibody
71213 100 µg
EUR 505
Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested.

TNFR2/TNFRSF1B/CD120b Neutralizing Antibody
MBS8111041-02mg 0.2mg
EUR 280

TNFR2/TNFRSF1B/CD120b Neutralizing Antibody
MBS8111041-05mg 0.5mg
EUR 375

TNFR2/TNFRSF1B/CD120b Neutralizing Antibody
MBS8111041-5x05mg 5x0.5mg
EUR 1545

TNFR1/CD120a/TNFRSF1A Neutralizing Antibody
MBS8104199-02mg 0.2mg
EUR 325

TNFR1/CD120a/TNFRSF1A Neutralizing Antibody
MBS8104199-05mg 0.5mg
EUR 455